Soricimed
Drug Discovery · Biotechnology
Overview
Soricimed Biopharma is a clinical stage drug development company dedicated to novel trageted treatments for cancer.
Funding and backers
Team
51-200
employees, estimated range
Backers
1
New Brunswick Innovation Foundation
Momentum
0/100
no fresh signals
Last sign of life
1 mo ago
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Backed byfrom the funds' portfolios and accelerator catalogs
Investors in similar startupsfunds that back the companies most like this one
backs Theora, AbInitio Bio
backs Babylon
backs DVLP Medicines
backs Babylon
backs Babylon
backs Babylon
Similar startupsby what they do, their industry and backers
Windward Bio is a clinical-stage, drug development company committed to improving outcomes for people living with serious immunological…
Psylink is a biotechnology company offering a novel solution to psychedelic drug development.
Abinitio bio is the AI-native operating platform for drug development and manufacturing.
Babylon is a drug development company pursuing a transformational treatment for Alzheimer’s. Meet our team and explore how we discover…
AllRock Bio is leveraging extensive expertise from drug development to commercialization. AllRock Bio’s team is dedicated to advancing…
Weatherden is a global drug development consultancy helping biotech and pharma realize the full potential of their science and investment.
Connections
List
Graph
Found in company registers, site code, DNS and hiring. Each connection shows how sure we are and the evidence, with its source and date.
Shared investors
New Brunswick Innovation FoundationVia a fund
Click a company to open it. Dashed lines are likely connections. The second step of the network is part of the Pro plan.
Owner
Same company
Same group
Likely
Shared investors
News
Star Tribune
Your source for Minnesota news today. Read articles, view photos or watch videos about news in Minneapolis, St. Paul, Duluth, St. Cloud, Rochester, and beyond.
Read more
Report
